Literature DB >> 6144556

Effects of spasmolytics on K+-induced contraction of rat intestine in vivo.

A Subissi, P Brunori, M Bachi.   

Abstract

Eight spasmolytic drugs commonly used in the treatment of the irritable bowel syndrome were compared to verapamil with respect to their effects (all drugs injected i.v.) on the contraction of duodenum, ileum and colon induced by high K+ topical application in the anaesthetized rat. Verapamil greater than rociverine greater than papaverine greater than mebeverine greater than dicyclomine antagonized dose-dependently the contraction of duodenum and colon, the activity on duodenum being from 2 (rociverine) to 10 (verapamil) fold higher. Verapamil and rociverine, but not the other drugs mentioned above, were also active on ileum. N-Butylscopolammonium bromide, phloroglucinol and trimebutine were inactive against the contraction of the three intestinal tracts and prifinium bromide was inactive on duodenum and ileum, while it had remarkable activity on colon, unrelated to its antimuscarinic activity. The results are discussed briefly with reference to the pharmacological therapy of the irritable bowel syndrome.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6144556     DOI: 10.1016/0014-2999(83)90320-5

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  4 in total

Review 1.  Efficacy of phloroglucinol for treatment of abdominal pain: a systematic review of literature and meta-analysis of randomised controlled trials versus placebo.

Authors:  Clara Blanchard; Denis Pouchain; Paul Vanderkam; Marie-Christine Perault-Pochat; Rémy Boussageon; Hélène Vaillant-Roussel
Journal:  Eur J Clin Pharmacol       Date:  2018-01-19       Impact factor: 2.953

2.  Efficacy of phloroglucinol for the treatment of pain of gynaecologic or obstetrical origin: a systematic review of literature of randomised controlled trials.

Authors:  Blanchard Clara; Vanderkam Paul; Pouchain Denis; Mignot Stéphanie; Vaillant-Roussel Hélène; Boussageon Rémy
Journal:  Eur J Clin Pharmacol       Date:  2019-08-21       Impact factor: 2.953

Review 3.  Role of antispasmodics in the treatment of irritable bowel syndrome.

Authors:  Anita Annaházi; Richárd Róka; András Rosztóczy; Tibor Wittmann
Journal:  World J Gastroenterol       Date:  2014-05-28       Impact factor: 5.742

Review 4.  Antispasmodics for Chronic Abdominal Pain: Analysis of North American Treatment Options.

Authors:  Darren M Brenner; Brian E Lacy
Journal:  Am J Gastroenterol       Date:  2021-08-01       Impact factor: 12.045

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.